INTRODUCTION: Up to 50% of patients with ST elevation myocardial infarction (STEMI) have ≥ 50% stenosis in a major non-infarct-related artery. Several studies have evaluated the prognostic value of the completion of revascularization with overall inconclusive results. Selection of the stenoses was based on the angiographic evaluation, invasive hemodynamic measurement or the combined approach. It is unknown whether such a selection provides correlation of comparable patient groups. MATERIAL AND METHODS: We enrolled 51 patients (62.7 ±10.2 years) with acute STEMI and at least one residual (50-90%) stenosis in a non-infarct-related major coronary artery (excluding left main coronary artery). Overall 65 stenoses (67.9 ±10.7%) were evaluated angiographically following primary percutaneous coronary intervention and the hemodynamic significance was estimated with respect to the stenosis severity, caliber of the arterial segment, localization of the stenosis (proximity) as well as the estimated size of the supplied vascular territory. During subsequent hospitalization, invasive measurement of the hemodynamic significance using fractional flow reserve (FFR) was performed to guide the final revascularization strategy (FFR value of ≤ 0.80 considered significant). RESULTS: Based on angiographic evaluation, a total of 44 stenoses would be recommended for treatment, whereas only 31 stenoses were revascularized based on FFR measurement. Moreover, visual evaluation and hemodynamic measurement were discrepant in 27 of 65 (41.5%) stenoses. CONCLUSIONS: We observed a weak correlation between visual angiographic evaluation and invasive hemodynamic measurement. More stents would be implanted based on angiographic evaluation compared to FFR measurement.

Department of Internal Medicine 1 Cardiology Faculty of Medicine and Dentistry Palacky University Olomouc and University Hospital Olomouc Olomouc Czech Republic

Department of Nuclear Medicine Faculty of Medicine and Dentistry Palacky University Olomouc and University Hospital Olomouc Olomouc Czech Republic

Zobrazit více v PubMed

Lloyd-Jones D, Adams RJ, Brown TM, et al. . American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010; 121: 948-54. PubMed

O’Gara PT, Kushner FG, Ascheim DD, et al. . 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61: e78-140. PubMed

Ibanez B, James S, Agewall S, et al. . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39: 119-77. PubMed

Sorajja P, Gersh BJ, Cox DA, et al. . Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 2007; 28: 1709-16. PubMed

Dziewierz A, Siudak Z, Rakowski T, Zasada W, Dubiel JS, Dudek D. Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry). Am J Cardiol 2010; 106: 342-7. PubMed

Wald DS, Morris JK, Wald NJ, et al. . Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013; 369: 1115-23. PubMed

Gershlick AH, Khan JN, Kelly DJ, et al. . Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol 2015; 65: 963-72. PubMed PMC

Engstrom T, Kelbaek H, Helqvist S, et al. . Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet 2015; 386: 665-71. PubMed

Smits PC, Abdel-Wahab M, Neumann FJ, et al. . Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med 2017; 376: 1234-44. PubMed

Mehta SR, Wood DA, Storey RF, et al. . Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med 2019; 381: 1411-21. PubMed

Knuuti J, Wijns W, Saraste A, et al. . 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J 2020; 41: 407-77. PubMed

Rigattieri S, Biondi-Zoccai G, Silvestri P, et al. . Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty. J Interv Cardiol 2008; 21: 1-7. PubMed

Hannan EL, Samadashvili Z, Walford G, et al. . Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv 2010; 3: 22-31. PubMed

Toma M, Buller CE, Westerhout CM, et al. . Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. Eur Heart J 2010; 31: 1701-7. PubMed

Xaplanteris P, Fournier S, Pijls NHJ, et al. . Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med 2018; 379: 250-9. PubMed

Maron DJ, Hochman JS, Reynolds HR, et al. . Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 2020; 382: 1395-407. PubMed PMC

Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003; 107: 2900-7. PubMed

Tonino PAL, Fearon WF, De Bruyne B, et al. . Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010; 55: 2816-21. PubMed

Puymirat E, Cayla G, Simon T, et al. . Multivessel PCI guided by FFR or angiography for myocardial infarction. N Engl J Med 2021; 385: 297-308. PubMed